Tiamat Sciences
Durham
About Tiamat Sciences
Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors. The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80% growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.5M
- Funding stage: Seed
- Last round: Seed (Mar 2023)
- Website: tiamat-sciences.com
- Phone: [email protected]
Industries & Categories
AgTech, Biotechnology, Food and Beverage, Medical
Social Profiles
Canonical: https://fsome.com/organization/tiamat-sciences-104600 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.